These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7652503)

  • 21. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
    Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
    Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children.
    Goldwater PN
    Int J Antimicrob Agents; 2005 Nov; 26(5):408-11. PubMed ID: 16216469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is it safe to use carbapenems in patients with a history of allergy to penicillin?
    Sodhi M; Axtell SS; Callahan J; Shekar R
    J Antimicrob Chemother; 2004 Dec; 54(6):1155-7. PubMed ID: 15486083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulary review of the carbapenems: comparison of imipenem/cilastatin and meropenem.
    Richerson MA; Ambrose PG; Quintiliani R; Nightingale CH
    Conn Med; 1998 Mar; 62(3):165-9. PubMed ID: 9573653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
    El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B
    APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of meropenem in bacterial meningitis].
    Fernández Viladrich P
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():57-61. PubMed ID: 9410071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meropenem: laboratory and clinical data.
    Drusano G
    Clin Microbiol Infect; 1997 Feb; 3 Suppl 4():S51-S59. PubMed ID: 11869241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbapenems in clinical practice: a guide to their use in serious infection.
    Bradley JS; Garau J; Lode H; Rolston KV; Wilson SE; Quinn JP
    Int J Antimicrob Agents; 1999 Feb; 11(2):93-100. PubMed ID: 10221411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meropenem versus Cefotaxime and Ampicillin as Empirical Antibiotic Treatment in Adult Bacterial Meningitis: a Quality Registry Study, 2008 to 2016.
    Brink M; Glimåker M; Sjölin J; Naucler P
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31501148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbapenems in pediatrics.
    Ayalew K; Nambiar S; Yasinskaya Y; Jantausch BA
    Ther Drug Monit; 2003 Oct; 25(5):593-9. PubMed ID: 14508383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations.
    Miller AD; Ball AM; Bookstaver PB; Dornblaser EK; Bennett CL
    Pharmacotherapy; 2011 Apr; 31(4):408-23. PubMed ID: 21449629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of meropenem in hospitalised children: randomised comparison with cefotaxime, alone and combined with metronidazole or amikacin. Meropenem Paediatric Study Group.
    Schuler D
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():99-108. PubMed ID: 8543503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children.
    Sáez-Llorens X; Castaño E; García R; Báez C; Pérez M; Tejeira F; McCracken GH
    Antimicrob Agents Chemother; 1995 Apr; 39(4):937-40. PubMed ID: 7785999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Carbapenems in pediatrics].
    Aujard Y
    Arch Pediatr; 1996; 3 Suppl 1():298s-301s. PubMed ID: 8796048
    [No Abstract]   [Full Text] [Related]  

  • 35. Carbapenems.
    Norrby SR
    Med Clin North Am; 1995 Jul; 79(4):745-59. PubMed ID: 7791421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurotoxicity of carbapenem antibiotics: consequences for their use in bacterial meningitis.
    Norrby SR
    J Antimicrob Chemother; 2000 Jan; 45(1):5-7. PubMed ID: 10629006
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical pharmacology and indications of meropenem in severe pediatric infection].
    Honorato J; Sádaba B; Díaz M
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():38-44. PubMed ID: 9410068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Listeria monocytogenes meningitis in a penicillin-allergic paediatric renal transplant patient.
    Weston VC; Punt J; Vloebeghs M; Watson AR; Ispahani P
    J Infect; 1998 Jul; 37(1):77-8. PubMed ID: 9733389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of cefotaxime in the treatment of purulent meningitis in children.
    Kobayashi Y; Morikawa Y; Haruta T; Fujii R; Meguro H; Hori M; Kurosu Y; Toyonaga Y; Iwai N; Kitamura I; Hamawaki M; Ozaki H; Nishimura T
    Clin Ther; 1981; 4 Suppl A():89-110. PubMed ID: 6276000
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety profile of meropenem: a review of nearly 5,000 patients treated with meropenem.
    Norrby SR; Gildon KM
    Scand J Infect Dis; 1999; 31(1):3-10. PubMed ID: 10381210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.